BASKING RIDGE, N.J., Apr 19, 2010 -- Hooper Holmes (NYSE Amex:HH) today announced that Christopher J. Behling, President of the Company's Health and Wellness Division, has been appointed a Senior Fellow (non-faculty affiliate) with the Jefferson School of Population Health (JSPH) at Thomas Jefferson University.
"Our mission is to prepare tomorrow's leaders to imagine and build a new healthcare future," said Dr. David B. Nash, Dean of the Jefferson School of Population Heath. "Our Senior Fellows play important roles in that work, and we are very pleased to welcome Chris Behling to our community."
Mr. Behling commented, "I am honored by this appointment and look forward to supporting the school's research agenda, Master's Programs, mentoring goals, and publications. The work of the JSPH has much to contribute to our major national healthcare priorities of improving outcomes and reducing costs."
About the Jefferson School of Population Health
The Jefferson School of Population Health (JSPH) is an integral part of Thomas Jefferson University, a premier academic health center founded in 1824 and located in Center City Philadelphia. Jefferson provides a robust learning community comprised of clinicians, physicians, researchers, and educators. JSPH prepares leaders with global vision to develop, implement, and evaluate health policies and systems that improve the health of populations and thereby enhance the quality of life. The school fulfills this mission by providing exemplary graduate academic programming, continuing education courses and conferences, and sustained research and consulting in areas of health policy, population health, healthcare quality and safety, and chronic care management.
About Hooper Holmes
Hooper Holmes (NYSE Amex:HH) is a leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. With a network of thousands of examiners, Hooper Holmes can arrange medical exams anywhere in the U.S. and deliver the results to its customers. Hooper Holmes provides a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, and lab testing and data transmission.
This press release contains "forward-looking" statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our ability to successfully implement our business strategy; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenant in our credit facility; our expectations regarding our operating cash flows; and the rate of life insurance application activity. Additional information about these and other factors that could affect the Company's business is set forth in the Company's annual report on Form 10-K for the year ended December 31, 2009, filed with the Securities and Exchange Commission on March 12, 2010. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.